Head & neck · 2003
Anterior skull base surgery for malignant tumors: a multivariate analysis of 27 years of experience.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Bentz Brandon G, Bilsky Mark H, Shah Jatin P, Kraus Dennis
Аннотация
INTRODUCTION: Few studies have examined prognostic factors that have an impact on outcomes in anterior skull base surgery by multivariate analysis.
METHODS: We retrospectively examined our institution's skull base experience from 1973-2000.
RESULTS: During this time, 166 patients underwent an anterior skull base resection for malignancy (median age, 53 years; range, 6-92 years). The 5-year relapse-free and disease-specific survival was 41% and 57% (median follow-up, 53 months). Multivariate analysis found that dural invasion, primary histologic diagnosis, and margin status had a significant impact on relapse-free and disease-specific survival.
CONCLUSIONS: These data indicate that patients with anterior skull base malignancies are treated successfully with skull base surgery. Patients demonstrating adverse prognostic variables such as dural invasion, adverse histologic findings, and/or positive margins should be considered for the addition of adjuvant therapy or innovative therapies as they become available in the future.
METHODS: We retrospectively examined our institution's skull base experience from 1973-2000.
RESULTS: During this time, 166 patients underwent an anterior skull base resection for malignancy (median age, 53 years; range, 6-92 years). The 5-year relapse-free and disease-specific survival was 41% and 57% (median follow-up, 53 months). Multivariate analysis found that dural invasion, primary histologic diagnosis, and margin status had a significant impact on relapse-free and disease-specific survival.
CONCLUSIONS: These data indicate that patients with anterior skull base malignancies are treated successfully with skull base surgery. Patients demonstrating adverse prognostic variables such as dural invasion, adverse histologic findings, and/or positive margins should be considered for the addition of adjuvant therapy or innovative therapies as they become available in the future.
Предметные рубрики MeSH
AdenocarcinomaAdolescentAdultAgedAged, 80 and overCarcinoma, Squamous CellChildDura MaterEsthesioneuroblastoma, OlfactoryFemaleHumansMaleMiddle AgedMultivariate AnalysisNasal CavityNeoplasm InvasivenessNeoplasm Recurrence, LocalNose NeoplasmsPostoperative ComplicationsProportional Hazards ModelsRetrospective StudiesSarcomaSkull Base NeoplasmsSurvival Analysis